Anti-Zika Virus (PRVABC59) [Rat#24] Antibody

This rat polyclonal antibody was raised against live whole zika virus infection, formalin-fixed virus boost and recognizes zika virus.

Highlights:

  • Recognizes whole zika virus
  • Rat was not pregnant and was infected with 106 PFU Zika, strain PRV59ABC/Puerto Rico/Human/Dec 2015
  • Suitable for IFA and VN titer applications

Zika virus (ZIKV) is a member of the virus family Flaviviridae and the genus Flavivirus, transmitted by daytime-active Aedes mosquitoes. Zika is related to other mosquito transmitted viruses such as dengue, yellow fever, Japanese encephalitis and west nile. Similar to other flaviviruses, ZIKV is enveloped and icosahedral and has a nonsegmented, single-stranded, positive-sense RNA genome. Common symptoms of infection with the virus include mild headaches, maculopapular rash, fever, malaise, conjunctivitis, and joint pains. Zika has been shown to cause microcephaly in babies exposed in utero.

From the laboratory of Mark S. Parcells, PhD, University of Delaware.

Catalog Number Product Size AVAILABILITY Price Qty
EDW004
Anti-Zika Virus (PRVABC59) [Rat#24] Antibody, 100uL
100uL In stock
Price: $299.00
Specifications
Product Type: Antibody
Antigen: Zika, PRVABC59 (Human/Puerto Rico/2015)
Accession ID: ATCC # VR-1846
Clonality: Polyclonal
Clone Name: Rat#24
Reactivity: Zika virus
Immunogen: Live whole virus infection, formalin-fixed virus boost
Species Immunized: Rat
Method Used to Determine Concentration: Immunofluorescence (IFA)
Buffer: Whole serum
Concentration: IFA titer 1: 810
Storage: -80C
Shipped: Dry Ice
Data

Epifluorescence using a Nikon TE-2000 scope, with NIS-Elements software

Provider
From the laboratory of Mark S. Parcells, PhD, University of Delaware.
Comments
This rat serum has not been tested or treated to inactivate any infectivity. Although it is unlikely to have virus, given the timing of serum collection, it should be handled as if potentially infectious.
References

If you publish research with this product, please let us know so we can cite your paper.

 
Loading...
Loading...